Moreover, ACE2 polymorphisms such as rs2285666 and rs2106809 have emerged as potential predictors of both severe disease and long COVID, reinforcing the importance of these genetic markers in understanding COVID-19 outcomes and guiding personalized approaches to risk assessment and clinical management. The gene discussed is ACE2; the disease is COVID-19.